Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial
SFT Kølle, A Fischer-Nielsen, AB Mathiasen, JJ Elberg… - The Lancet, 2013 - thelancet.com
Background Autologous fat grafting is increasingly used in reconstructive surgery. However,
resorption rates ranging from 25% to 80% have been reported. Therefore, methods to …
resorption rates ranging from 25% to 80% have been reported. Therefore, methods to …
Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial.
SF Kølle, A Fischer-Nielsen, AB Mathiasen… - Lancet (London …, 2013 - europepmc.org
Background Autologous fat grafting is increasingly used in reconstructive surgery. However,
resorption rates ranging from 25% to 80% have been reported. Therefore, methods to …
resorption rates ranging from 25% to 80% have been reported. Therefore, methods to …
Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial
SFT Kølle, A Fischer-Nielsen, AB Mathiasen, JJ Elberg… - 2013 - pubmed.ncbi.nlm.nih.gov
Background Autologous fat grafting is increasingly used in reconstructive surgery. However,
resorption rates ranging from 25% to 80% have been reported. Therefore, methods to …
resorption rates ranging from 25% to 80% have been reported. Therefore, methods to …
Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial
SFT Kølle, A Fischer-Nielsen, AB Mathiasen, JJ Elberg… - Lancet, 2013 - research.regionh.dk
Autologous fat grafting is increasingly used in reconstructive surgery. However, resorption
rates ranging from 25% to 80% have been reported. Therefore, methods to increase graft …
rates ranging from 25% to 80% have been reported. Therefore, methods to increase graft …
Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial
SFT Kølle, A Fischer-Nielsen, AB Mathiasen, JJ Elberg… - The Lancet, 2013 - infona.pl
Autologous fat grafting is increasingly used in reconstructive surgery. However, resorption
rates ranging from 25% to 80% have been reported. Therefore, methods to increase graft …
rates ranging from 25% to 80% have been reported. Therefore, methods to increase graft …
[PDF][PDF] Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial
SFT Kølle, A Fischer-Nielsen, AB Mathiasen, JJ Elberg… - Lancet, 2013 - academia.edu
Background Autologous fat grafting is increasingly used in reconstructive surgery. However,
resorption rates ranging from 25% to 80% have been reported. Therefore, methods to …
resorption rates ranging from 25% to 80% have been reported. Therefore, methods to …
[引用][C] Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial
SFT Kølle, A Fischer-Nielsen, AB Mathiasen, JJ Elberg… - The Lancet, 2013 - cir.nii.ac.jp
Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells
for graft survival: a randomised placebo-controlled trial | CiNii Research CiNii 国立情報学 …
for graft survival: a randomised placebo-controlled trial | CiNii Research CiNii 国立情報学 …
Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial
SFT Kølle, A Fischer-Nielsen, AB Mathiasen, JJ Elberg… - The Lancet, 2013 - thelancet.com
Background Autologous fat grafting is increasingly used in reconstructive surgery. However,
resorption rates ranging from 25% to 80% have been reported. Therefore, methods to …
resorption rates ranging from 25% to 80% have been reported. Therefore, methods to …
[引用][C] Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial
SF TROJAHN KØLLE… - Lancet (British …, 2013 - pascal-francis.inist.fr
Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells
for graft survival: a randomised placebo-controlled trial CNRS Inist Pascal-Francis CNRS …
for graft survival: a randomised placebo-controlled trial CNRS Inist Pascal-Francis CNRS …